Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer
Conditions
- Estrogen-receptor-positive Breast Cancer
- HER2/Neu-Negative Breast Cancer
- Advanced Breast Cancerv
- Metastatic Breast Cancer
Interventions
- DRUG: elacestrant, palbociclib, abemaciclib, ribociclib
Sponsor
Northwestern University
Collaborators